BEIJING/SAO PAULO, (Reuters) - An experimental vaccine developed by China’s Sinovac Biotech appeared to be safe in providing protection against the COVID-19 disease caused by the new coronavirus, preliminary results of a late stage clinical trial conducted in Brazil showed yesterday.
The article Brazil’s Butantan says tests show vaccine by China’s Sinovac is safe appeared first on Stabroek News.
